Paper - WANFANG MED ONLINE

You Position: Home > Paper

Role of HDAC6 in primary digestive system malignancies

( views:15, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 14

DOI:: 10.11569/wcjd.v26.i14.827

Key Word:: 蛋白质翻译后修饰;组蛋白去乙酰化酶6;消化系统恶性肿瘤

Abstract：恶性肿瘤已成为继心血管疾病外全球第二大死亡原因.消化系统恶性肿瘤的发病率和死亡率在我国恶性肿瘤排名中均位居前列.肿瘤的发生发展是一个多因素参与、多阶段的过程,蛋白质的乙酰化和去乙酰化在肿瘤的发生发展中起着重要作用.蛋白质的去乙酰化由组蛋白去乙酰化酶(histone deacetylases,HDACs)调控.目前共发现1 8个HDACs,其中HDAC6是该家族中研究最广泛的一类亚型.HDAC6已被证实在多种肿瘤组织中呈高表达状态,并与患者临床病理特征密切相关,HDAC6选择性抑制剂可抑制多种肿瘤细胞生长.本文就HDAC6在消化系统原发恶性肿瘤中的作用及潜在应用价值进行作一述评.

Reference

[1]杨晋,赵绍林,杨新玲,等.HDAC6在食道癌中表达的初步研究[J].2009,(11).
[2]任月霞.组蛋白去乙酰化酶6（HDAC6）在食管鳞癌组织中的表达及其意义[D].2011.
[3]李斌,王济明,梁艳.应用激光显微切割技术检测组蛋白去乙酰化酶6在肝癌中的表达[J].2007,(9).
[4]李光明,李能莲,张岭漪,等.组蛋白去乙酰化酶6在胃癌中的表达及意义[J].2014,(13).
[5]罗平.HDAC6在食管癌中的表达及其临床意义[D].2011.
[6]李逸,王子卫,孔德全,等.胃癌中HMGA2与HDAC6表达的临床意义及其相关性[J].2016,(6).
[7]张文靖,杨建萍,李晟磊.组蛋白去乙酰化酶6在胃癌组织中的表达及意义[J].2012,(2).
[8]管克平.HDAC2和HDAC6在新疆哈萨克族食管鳞癌中的表达及意义[J].2014,(12).
[9]宁静.HDAC6在小肠癌组织及肠癌细胞中的表达及其下调对肠癌细胞增殖能力的影响[J].2017,(22).
[10]李群,胡卫红,李斌,等.HDAC6在胃癌组织中的表达[J].2010,(11).
[11]张峰.HDAC6 mRNA在食管鳞癌组织中的表达及其临床意义[D].2013.
[12]Bae, Hyun Jin,Jung, Kwang Hwa,Eun, Jung Woo,etc.MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer[J].2015,63(2).
[13]刘轩,乔晓娟,杜华,等.组蛋白去乙酰化酶6在大肠癌中表达及意义[J].2016,(11).
[14]Otto, Tobias,Sicinski, Piotr.Cell cycle proteins as promising targets in cancer therapy[J].2017,17(2).
[15]Katz, Stephen I.,Tsuji, Gaku,Villarroel, Vadim A.,etc.Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation[J].2015,135(5).
[16]Sirintip Boonjaraspinyo,Thidarut Boonmars,Sasithorn Kaewkes,etc.Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.[J].2012,18(2).
[17]Lee YS,Lim KH,Guo X,etc.The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.[J].2008,68(18).
[18]RUIJTER Annemieke J.M. de,GENNIP Albert H. van,CARON Huib N.,etc.Histone deacetylases (HDACs): characterization of the classical HDAC family[J].2003.
[19]Ryu, Hyun-Wook,Lee, Dong-Hun,Shin, Dong-Hee,etc.Aceroside VIII is a New Natural Selective HDAC6 Inhibitor that Synergistically Enhances the Anticancer Activity of HDAC Inhibitor in HT29 Cells[J].2015,81(3).
[20]Opipari,A.W.,Kwok,R.P.S.,Subramanian,C.,etc.HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma[J].2011,13(8).
[21]Riolo,M.T.,Cooper,Z.A.,Holloway,M.P.,etc.Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer[J].2012,287(14).
[22]Angela Nieto, M.,Huang, Ruby Yun-Ju,Jackson, Rebecca A.,etc.Emt: 2016[J].2016,166(1).
[23]Li Ning,Tie Xiao-Jing,Liu Pei-Jie,etc.","Effects of Down-regulation of HDAC6 Expression on Proliferation, Cell Cycling and Migration of Esophageal Squamous Cell Carcinoma Cells and Related Molecular Mechanisms[J].2013,14(2).
[24]Kozikowski AP,Tapadar S,Luchini DN,etc.Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: A new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6[J].2008,51(15).
[25]Dengwen Li,Xiaodong SUN,Linlin Zhang,etc.Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells[J].2014,(3).
[26]North, Brian J.,Almeciga-Pinto, Ingrid,Tamang, David,etc.Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.[J].2017,12(3).
[27]Fang, Li Tai,Lee, Sharon,Choi, Helen,etc.Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis[J].2014,44(1).
[28]Yang, Zhuang,Wang, Taijin,Wang, Fang,etc.Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer[J].2016,59(4).
[29]Yao TP,Nguyen HT,Lasky JA,etc.Requirement of HDAC6 for transforming growth factor-beta(1)-induced epithelial-mesenchymal transition[J].2008,283(30).
[30]He Q.,·Li G.,·Wang X.,etc.A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer[J].2017,42(4).
[31]Noh,J.H.,Chu,I.-S.,Kim,J.K.,etc.Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer[J].2012,56(2).
[32]Shuchen, Gu,Yanjing, Liu,Bowen, Zhu,etc.Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition.[J].2016.
[33]Weng, Xiaoyu,Zhou, Lin,Cai, Xianlei,etc.Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients[J].2016,55(5).
[34]Chen Y,Lopez-Sanchez M,Dow GS,etc.A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum[J].2008,51(12).
[35]Se Jin Park,Jeong Kyu Kim,Hyun Jin Bae,etc.HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer[J].2014,354(1).
[36]Xun, Chen,Ning, Duan,Caiguo, Zhang,etc.Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.[J].2016.
[37]Joshua, Haakenson,Jheng-Yu, Wu,Shengyan, Xiang,etc.HDAC6-Dependent Functions in Tumor Cells: Crossroad with the MAPK Pathways.[J].2015,20(1-2).